Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.46 |
| ▸ | MAOA | P21397 | 1/20 | 0.44 |
| ▸ | MAOB | P27338 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 4/20 | 0.39 |
| ▸ | CA2 | P00918 | 4/20 | 0.39 |
| ▸ | CA12 | O43570 | 2/20 | 0.39 |
| ▸ | CA9 | Q16790 | 2/20 | 0.39 |
| ▸ | SYK | P43405 | 1/20 | 0.39 |
| ▸ | CAPN1 | P07384 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | TLR2 | O60603 | 1/20 | 0.37 |
| ▸ | TLR1 | Q15399 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | CTSK | P43235 | 3/20 | 0.36 |
| ▸ | CTSS | P25774 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16077485 | 1.00 | MEN1 (0.47) | MEN1KMT2AGAATDP1MAOA | |
| SCHEMBL13741526 | 0.86 | MEN1 (0.52) | MEN1KMT2AGAATDP1MAOA | |
| SCHEMBL14723706 | 0.81 | TDP1 (0.66) | MEN1KMT2AGAATDP1MAOA | |
| SCHEMBL6244166 | 0.80 | MEN1 (0.62) | MEN1KMT2AGAATDP1MAOA | |
| SCHEMBL9017485 | 0.80 | TDP1 (0.56) | MEN1KMT2AGAATDP1MAOA | |
| SCHEMBL24096052 | 0.79 | TDP1 (0.58) | MEN1KMT2AGAATDP1MAOA | |
| SCHEMBL7799440 | 0.78 | SYK (0.44) | MEN1KMT2AGAATDP1MAOA | |
| SCHEMBL3311637 | 0.77 | TDP1 (0.75) | MEN1KMT2AGAATDP1MAOA | |
| SCHEMBL16152420 | 0.77 | CTSS (0.51) | MEN1KMT2AGAATDP1MAOA | |
| SCHEMBL22929002 | 0.76 | TDP1 (0.78) | MEN1KMT2AGAATDP1MAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170202972-A1 | SUBCUTANEOUS DELIVERY OF POLYMER CONJUGATES OF THERAPEUTIC AGENTS | SERINA THERAPEUTICS (AL), INC. | 2017-07-20 | — | — | US | disclosed |
| US-20160303250-A1 | Subcutaneous Delivery of Poly(oxazoline) Polymer Conjugates | SERINA THERAPEUTICS (AL), INC. | 2016-10-20 | — | — | US | disclosed |
| US-20140112880-A1 | SUBCUTANEOUS DELIVERY OF POLY(OXAZOLINE) POLYMER CONJUGATES | SERINA THERAPEUTICS, INC. (US) | 2014-04-24 | — | — | US | disclosed |
| US-20130177521-A1 | Subcutaneous Delivery of Poly(oxazoline) Conjugates | SERINA THERAPEUTICS, INC. (US) | 2013-07-11 | — | — | US | disclosed |
| US-8383093-B1 | Subcutaneous delivery of poly(oxazoline) conjugates | SERINA THERAPEUTICS, INC. (US) | 2013-02-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130177521-A1 | Subcutaneous Delivery of Poly(oxazoline) Conjugates | OXA1L, PAICS, PAM | MEN1 4043/4885KMT2A 686/4885GAA 303/4885 |
| US-20170202972-A1 | SUBCUTANEOUS DELIVERY OF POLYMER CONJUGATES OF THERAPEUTIC AGENTS | CD44, CD47, LNPEP | MEN1 2864/4885KMT2A 2735/4885GAA 229/4885 |
| US-20140112880-A1 | SUBCUTANEOUS DELIVERY OF POLY(OXAZOLINE) POLYMER CONJUGATES | OXA1L, PAM, JMJD7 | MEN1 4084/4885KMT2A 734/4885GAA 180/4885 |
| US-20160303250-A1 | Subcutaneous Delivery of Poly(oxazoline) Polymer Conjugates | OXA1L, PAM, JMJD7 | MEN1 4084/4885KMT2A 734/4885GAA 180/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.